As number of COVID-19 cases in Russia crossed 500,000, the government has rolled out a drug to treat the novel coronavirus even though clinical trials are still underway.
The country's health ministry has approved the use of the anti-viral drug, registered under the name Avifavir, under a special accelerated process.
In a press release, the state financial backer said the drug has been delivered to some hospitals and clinics in the country.
The country's RDIF sovereign wealth fund has a 50 per cent share in a joint venture with the drug's manufacturer ChemRar.
There is currently no vaccine for COVID-19, with human trials of several existing antiviral drugs yet to show efficacy.
So far, the country has 502,436 positive cases and the death toll stands at 6,532.
Trump says Iran really wants to make a deal with the US
Kuwaiti forces deal with missile, drone attacks on Monday
US says it struck Iranian drone command sites at weekend
US proposes new plan to ease Israel-Lebanon tensions amid fighting
Five dead, two injured after blast at Hanwha Aerospace plant in South Korea
